At t-6, the moderate disease activity criterion was fulfilled by 17/32 D2T-RA patients (53.1%), the raised CRP criterion by 19/32 patients (59.4%), and the glucocorticoid criterion by 18/32 (56.3%). The gene discussed is CRP; the disease is rheumatoid arthritis.